Remifentanil Hydrochloride Injection, Powder, Lyophilized, For Solution
Product Images NDC 63323-725

Product Visual Gallery

This gallery contains 10 technical images submitted to the FDA as part of the official labeling for Remifentanil Hydrochloride (NDC 63323-725). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Fresenius Kabi Usa, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Rem02 0004 01

Chemical structure diagram of Remifentanil Hydrochloride showing its molecular components and arrangement, including a cyclohexane ring, ester groups, and aromatic ring.*

FDA Label Image

Rem02 0004 02

Line graph comparing minute ventilation (% of baseline) over time (minutes) for Remifentanil Hydrochloride and Alfentanil. The x-axis shows time from -30 to 270 minutes, divided into 'During Infusion' and 'Post Infusion' phases. Data points with error bars illustrate ventilation changes in subjects receiving each drug.*

FDA Label Image

Rem02 0004 03

A line graph showing the mean concentration of Remifentanil Hydrochloride and Alfentanil in serum over time (minutes). The y-axis is labeled as mean serum concentration (ng/mL) on a logarithmic scale, and the x-axis as time in minutes. Two curves represent Remifentanil HCl at 0.05 mcg/kg/min and Alfentanil at 0.5 mcg/kg/min, with data points and error bars illustrating variability.*

FDA Label Image

Rem02 0004 04

Remifentanil Hydrochloride for Injection 1 mg per vial lyophilized powder for solution. The label states the product is equivalent to 1 mg of remifentanil and intended for intravenous use only. It must be reconstituted and diluted before use and is marked Rx only. The label shows Fresenius Kabi USA, LLC as the labeler.*

FDA Label Image

Rem02 0004 05

Label for Remifentanil Hydrochloride for Injection 1 mg per vial, lyophilized powder for solution. The label indicates intravenous use only, containing 10 single-dose vials of 1 mg each. Manufactured by Fresenius Kabi USA, LLC, Lake Zurich, IL.*

FDA Label Image

Rem02 0004 06

Label of Remifentanil Hydrochloride Injection, Powder, Lyophilized, for Solution showing strength of 2 mg per vial, equivalent to 2 mg of remifentanil, for intravenous use. Label includes prescription-only (Rx only) designation. Manufactured by Fresenius Kabi USA, LLC.*

FDA Label Image

Rem02 0004 07

Label for Remifentanil Hydrochloride for Injection, 2 mg per vial, lyophilized powder for solution. The packaging indicates 10 single-dose vials, each containing 2 mg of remifentanil for intravenous use only. The product is labeled by Fresenius Kabi USA, LLC, Lake Zurich, IL.*

FDA Label Image

Rem02 0004 08

Label for Remifentanil Hydrochloride for Injection, 5 mg per vial, lyophilized powder for intravenous administration. It indicates the product is a single dose vial, equivalent to 5 mg of remifentanil, and is restricted to prescription use only.*

FDA Label Image

Rem02 0004 09

Packaging label for Remifentanil Hydrochloride Injection, 5 mg per vial, lyophilized powder for solution. The label indicates 10 single-dose vials, for intravenous use only. The product is labeled by Fresenius Kabi USA, LLC, Lake Zurich, IL.*

FDA Label Image

Rem02 0004 10

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.